Scientists are exploring whether a single gene-editing treatment could one day provide decades of protection against heart disease, high cholesterol and other common conditions, potentially replacing the daily medications millions of patients rely on for life. The approach, still in experimental stages, targets genetic mechanisms linked to these conditions rather than managing symptoms through ongoing drug regimens. Proponents argue that a one-time intervention could improve adherence and reduce the cumulative burden on health systems, particularly for patients who struggle with long-term medication schedules.
However, researchers caution that permanently altering a person's genetic code carries risks that may not surface for years or even decades. Unlike conventional drugs, which can be stopped if side effects appear, gene edits are largely irreversible, raising questions about unintended consequences, off-target effects and the difficulty of long-term monitoring. Scientists say establishing safety will require extensive follow-up studies and robust regulatory oversight before such treatments can be considered for widespread use. For now, the promise of a lifetime of protection remains tempered by the unresolved challenge of proving that permanent genetic changes are safe over the long term.
Independent reporting synthesized from primary wires and global correspondents.